Publikationen in Zusammenarbeit mit Forschern von Instituto de Biomedicina de Valencia (19)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. A Very Rare Variant in SREBF2, a Possible Cause of Hypercholesterolemia and Increased Glycemic Levels

    Biomedicines, Vol. 10, Núm. 5

  2. A first update on mapping the human genetic architecture of COVID-19

    Nature

  3. Whole-genome sequencing reveals host factors underlying critical COVID-19

    Nature, Vol. 607, Núm. 7917, pp. 97-103

2021

  1. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  2. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2019

  1. Protective Role of Hepatocyte Cyclooxygenase-2 Expression Against Liver Ischemia–Reperfusion Injury in Mice

    Hepatology, Vol. 70, Núm. 2, pp. 650-665

2018

  1. Increased prevalence of pathogenic bacteria in the gut microbiota of infants at risk of developing celiac disease: The PROFICEL study

    Gut Microbes, Vol. 9, Núm. 6, pp. 551-558

  2. PGE2 induces apoptosis of hepatic stellate cells and attenuates liver fibrosis in mice by downregulating miR-23a-5p and miR-28a-5p

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 2, pp. 325-337

2016

  1. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, Núm. 9, pp. 1710-1723

2015

  1. Regulation of microRNA 183 by cyclooxygenase 2 in liver is DEAD-box helicase p68 (DDX5) dependent: Role in insulin signaling

    Molecular and Cellular Biology, Vol. 35, Núm. 14, pp. 2554-2567

2013

  1. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma

    International Journal of Biochemistry and Cell Biology, Vol. 45, Núm. 11, pp. 2501-2511

  2. Silencing of the Charcot-Marie-Tooth disease-associated gene GDAP1 induces abnormal mitochondrial distribution and affects Ca2+ homeostasis by reducing store-operated Ca2+ entry

    Neurobiology of Disease, Vol. 55, pp. 140-151

2012

  1. Cyclooxygenase-2 Is a Target of MicroRNA-16 in Human Hepatoma Cells

    PLoS ONE, Vol. 7, Núm. 11

  2. Influence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: The PROFICEL study

    PLoS ONE, Vol. 7, Núm. 2

2011

  1. Influence of environmental and genetic factors linked to celiac disease risk on infant gut colonization by Bacteroides species

    Applied and Environmental Microbiology, Vol. 77, Núm. 15, pp. 5316-5323

2008

  1. A new PCSK9 gene promoter variant affects gene expression and causes autosomal dominant hypercholesterolemia

    Journal of Clinical Endocrinology and Metabolism, Vol. 93, Núm. 9, pp. 3577-3583

2005

  1. Energetics of 5-bromo-4-chloro-3-indolyl-α-D-mannose binding to the Parkia platycephala seed lectin and its use for MAD phasing

    Acta Crystallographica Section F: Structural Biology and Crystallization Communications, Vol. 61, Núm. 3, pp. 326-331